Asters has advised the EBRD in connection with its up to EUR 15 million financing to JSC Farmak, a Ukrainian pharmaceuticals manufacturer.
The five-year loan will be used to support the expansion of Farmak’s production of liquid dosage forms and the modernization of its laboratories. According to Asters, the increased research and development and manufacturing capacity will help Farmak to develop and produce new drug formulations, meet relevant EU standards, compete on international markets, and increase its exports.
The Asters team consisted of Partner Iryna Pokanay, Counsel Gabriel Aslanian, and Associates Inna Bondarenko and Viktoria Zagreba.
